I bring up 3 cures of HIV that CytoDyn currently h

I bring up 3 cures of HIV that CytoDyn currently has in development: Everything is discussed In this post :

Quote:

---

" LATCH was introduced here in The Next Berlin Patient which I wrote about on 7/27/24. This showed that HIV could be cured via Stem Cell Transplant using normal Stem Cells. The Stem Cells do not need to have the CCR5 Delta 32 Variant. Powerful news to an organization like BMGF ."

---

Quote:

---

"Then towards the end of September, I wrote LS Mutations .

"Leronlimab-PLS = Leronlimab with Placenta LS mutation. This really is the main detail of the week. This news has very much to do with HIV and long acting leronlimab for HIV-PrEP. Could this news be a re-entry point for CytoDyn to pursue to gain re-entry into HIV using a form of long acting leronlimab, leronlimab-PLS? I believe it very well might be in order to prevent the transmission of HIV from mother to fetus/child around the time of birth . Somewhere around 150,000 patients annually . So more to come on this."
This work proved that leronlimab crosses the placenta and may potentially be used to prevent the transmission of HIV from mother to infant. Another powerful impact on the BMGF ."

---

Quote:

---

"In October, 2024, Jonah Sacha presented Short-term combination immunotherapy with broadly neutralizing antibodies and CCR5 blockade mediates ART-free viral control in infant rhesus macaques at the HIV/AIDS conference. This essentially shows that Jonah's team are on the brink of discovering an HIV CURE without the use of Stem Cells . They have found a means to prevent the formation of and possibly to remove existing reservoirs of HIV. This news to the BMGF had to be Earth shattering ."

---

Keep in mind, BMGF funded VIR-1388, but it was shut down and then a month later, Max Lataillade joins both CytoDyn and BMGF.